Ameriprise’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-212,667
| Closed | -$2M | – | 3888 |
|
|
2020
Q3 | $2M | Sell |
212,667
-17,662
| -8% | -$168K | ﹤0.01% | 2668 |
|
|
2020
Q2 | $1.76M | Sell |
230,329
-3,526
| -2% | -$27K | ﹤0.01% | 2673 |
|
|
2020
Q1 | $1.45M | Sell |
233,855
-9,210
| -4% | -$81.1K | ﹤0.01% | 2645 |
|
|
2019
Q4 | $2.96M | Buy |
243,065
+15,585
| +7% | +$170K | ﹤0.01% | 2532 |
|
|
2019
Q3 | $2.63M | Sell |
227,480
-12,455
| -5% | -$131K | ﹤0.01% | 2568 |
|
|
2019
Q2 | $2.4M | Buy |
239,935
+7,225
| +3% | +$77.9K | ﹤0.01% | 2639 |
|
|
2019
Q1 | $3M | Buy |
232,710
+20,095
| +9% | +$299K | ﹤0.01% | 2535 |
|
|
2018
Q4 | $3.23M | Sell |
212,615
-1,335
| -0.6% | -$25.4K | ﹤0.01% | 2408 |
|
|
2018
Q3 | $4.28M | Sell |
213,950
-33,790
| -14% | -$769K | ﹤0.01% | 2442 |
|
|
2018
Q2 | $4.83M | Buy |
247,740
+47,945
| +24% | +$1.06M | ﹤0.01% | 2268 |
|
|
2018
Q1 | $4.03M | Buy |
199,795
+17,660
| +10% | +$299K | ﹤0.01% | 2326 |
|
|
2017
Q4 | $2.41M | Sell |
182,135
-3,627
| -2% | -$54.7K | ﹤0.01% | 2571 |
|
|
2017
Q3 | $3.45M | Buy |
185,762
+305
| +0.2% | +$5.68K | ﹤0.01% | 2334 |
|
|
2017
Q2 | $3.41M | Buy |
185,457
+1,521
| +0.8% | +$30.1K | ﹤0.01% | 2335 |
|
|
2017
Q1 | $4.15M | Buy |
183,936
+6,192
| +3% | +$148K | ﹤0.01% | 2182 |
|
|
2016
Q4 | $6.19M | Buy |
177,744
+3,237
| +2% | +$96.7K | ﹤0.01% | 1863 |
|
|
2016
Q3 | $4.28M | Sell |
174,507
-95,898
| -35% | -$2.4M | ﹤0.01% | 2105 |
|
|
2016
Q2 | $6.47M | Sell |
270,405
-136,557
| -34% | -$3.13M | ﹤0.01% | 1750 |
|
|
2016
Q1 | $9.52M | Buy |
406,962
+240,178
| +144% | +$5.7M | 0.01% | 1449 |
|
|
2015
Q4 | $5.04M | Sell |
166,784
-325,473
| -66% | -$10.5M | ﹤0.01% | 2015 |
|
|
2015
Q3 | $19.6M | Buy |
492,257
+312,200
| +173% | +$19.4M | 0.01% | 951 |
|
|
2015
Q2 | $12.4M | Buy |
180,057
+93,195
| +107% | +$5.86M | 0.01% | 1393 |
|
|
2015
Q1 | $4.75M | Buy |
86,862
+34,784
| +67% | +$1.66M | ﹤0.01% | 2137 |
|
|
2014
Q4 | $2.22M | Buy |
52,078
+15,125
| +41% | +$546K | ﹤0.01% | 2516 |
|
|
2014
Q3 | $1.18M | Buy |
36,953
+36,923
| +123,077% | +$787K | ﹤0.01% | 2718 |
|
|
2014
Q2 | $1K | Buy |
+30
| New | +$554 | ﹤0.01% | 5413 |
|
|
2013
Q4 | – | Sell |
-1,345
| Closed | -$29K | – | 5507 |
|
|
2013
Q3 | $29K | Hold |
1,345
| – | – | ﹤0.01% | 4161 |
|
|
2013
Q2 | $30K | Buy |
+1,345
| New | +$29.6K | ﹤0.01% | 4039 |
|
Ameriprise's AMAG Position: Q4 2020 in Review
Ameriprise sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 212,667 shares — an estimated $2M sold.
Ameriprise first reported a position in AMAG in Q2 2013 and held it in 28 quarters. The position peaked at $19.6M in Q3 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Ameriprise reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Ameriprise sold 212,667 AMAG Pharmaceuticals shares in Q4 2020, an estimated $2M.
- Ameriprise first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 28 quarters.
- Ameriprise's AMAG Pharmaceuticals position peaked at $19.6M in Q3 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.